Pearl Kho

1.0k total citations
14 papers, 798 citations indexed

About

Pearl Kho is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Pearl Kho has authored 14 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Epidemiology and 4 papers in Physiology. Recurrent topics in Pearl Kho's work include Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Asthma and respiratory diseases (4 papers) and Pneumonia and Respiratory Infections (3 papers). Pearl Kho is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Asthma and respiratory diseases (4 papers) and Pneumonia and Respiratory Infections (3 papers). Pearl Kho collaborates with scholars based in United Kingdom, United States and Switzerland. Pearl Kho's co-authors include Gerhild Angyalosi, À. Munck, Félix Ratjen, Éliane Gluckman, Per Ljungman, LeAnne Kennedy, Nöel Milpied, Franco Mandelli, H. G. Prentice and H. G. Prentice and has published in prestigious journals such as The Lancet, European Respiratory Journal and Thorax.

In The Last Decade

Pearl Kho

14 papers receiving 777 citations

Peers

Pearl Kho
Takahito Nei Japan
Angelo Cazzadori Italy
Lars Öhrmalm Sweden
Toyomitsu Sawai Japan
Jeanine Hatfield United States
D. C. Turk United Kingdom
Daire O’Shea Canada
A Terragna Italy
Saul Rodriguez United States
Sarah Doffman United Kingdom
Takahito Nei Japan
Pearl Kho
Citations per year, relative to Pearl Kho Pearl Kho (= 1×) peers Takahito Nei

Countries citing papers authored by Pearl Kho

Since Specialization
Citations

This map shows the geographic impact of Pearl Kho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pearl Kho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pearl Kho more than expected).

Fields of papers citing papers by Pearl Kho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pearl Kho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pearl Kho. The network helps show where Pearl Kho may publish in the future.

Co-authorship network of co-authors of Pearl Kho

This figure shows the co-authorship network connecting the top 25 collaborators of Pearl Kho. A scholar is included among the top collaborators of Pearl Kho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pearl Kho. Pearl Kho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Sannigrahi, Santanu, Tieying Sun, Yijiang Huang, et al.. (2015). Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study. International Journal of COPD. 10. 57–57. 18 indexed citations
2.
Banerji, Donald, Angel FowlerTaylor, Pearl Kho, Hungta Chen, & Vijay Alagappan. (2013). Once-daily QVA149 provides superior improvements in lung function compared with glycopyrronium and tiotropium in severe COPD patients: A 52 week pooled analysis. European Respiratory Journal. 42(Suppl 57). P755–P755. 1 indexed citations
3.
Dahl, Ronald, Kenneth R. Chapman, Rajendra Mehta, et al.. (2013). Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: The ENLIGHTEN study. Respiratory Medicine. 107(10). 1558–1567. 79 indexed citations
4.
Dahl, Ronald, Kenneth R. Chapman, M. Rudolf, et al.. (2012). P190 QVA149 Once Daily Provides Significant Improvements in Lung Function Over 1 Year in Patients with COPD: The Enlighten Study: Abstract P190 Table 1. Thorax. 67(Suppl 2). A146.2–A147. 1 indexed citations
5.
Dahl, Ronald, Kenneth R. Chapman, Rajendra Mehta, et al.. (2012). QVA149 administered once daily provides significant improvements in lung function over 1 year in patients with COPD: The ENLIGHTEN study. 40. 2896. 3 indexed citations
6.
Lenney, Warren, F. Edenborough, Pearl Kho, & John M. Kovarik. (2010). Lung deposition of inhaled tobramycin with eFlow rapid/LC Plus jet nebuliser in healthy and cystic fibrosis subjects. Journal of Cystic Fibrosis. 10(1). 9–14. 60 indexed citations
7.
Hubert, D., Sylvie Leroy, R. Nové-Josserand, et al.. (2009). Pharmacokinetics and safety of tobramycin administered by the PARI eFlow® rapid nebulizer in cystic fibrosis. Journal of Cystic Fibrosis. 8(5). 332–337. 50 indexed citations
8.
Ratjen, Félix, et al.. (2009). Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Thorax. 65(4). 286–291. 224 indexed citations
9.
Prentice, H. G. & Pearl Kho. (1997). Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant. Bone Marrow Transplantation. 19(2). 135–142. 35 indexed citations
10.
Prentice, H. G., Éliane Gluckman, R Powles, et al.. (1997). Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. Bone Marrow Transplantation. 19(2). 129–133. 64 indexed citations
11.
Prentice, H. G., Éliane Gluckman, R Powles, et al.. (1994). Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. The Lancet. 343(8900). 749–753. 221 indexed citations
12.
Patterson, Adam V., et al.. (1990). A comparison of local and systemic acyclovir in the management of herpetic disciform keratitis.. British Journal of Ophthalmology. 74(5). 283–285. 25 indexed citations
13.
Livermore, David M., et al.. (1986). Behaviour of TEM-1 β-lactamase as a resistance mechanism to ampicillin, mezlocillin and azlocillin in Escherichia coli. Journal of Antimicrobial Chemotherapy. 17(2). 139–146. 16 indexed citations
14.
Smales, F. C., et al.. (1983). The Evaluation of a New Technique for Anaerobic Sampling of Deep Periodontal Pockets. Journal of Periodontology. 54(6). 354–356. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takahito Nei Breakdown of academic impact, for papers by Angelo Cazzadori Breakdown of academic impact, for papers by Lars Öhrmalm Breakdown of academic impact, for papers by Toyomitsu Sawai Breakdown of academic impact, for papers by Jeanine Hatfield Breakdown of academic impact, for papers by D. C. Turk Breakdown of academic impact, for papers by Daire O’Shea Breakdown of academic impact, for papers by A Terragna Breakdown of academic impact, for papers by Saul Rodriguez Breakdown of academic impact, for papers by Sarah Doffman
Rankless by CCL
2026